论文部分内容阅读
目的探讨倍他乐克与常规抗心力衰竭药物联合应用方案治疗充血性心力衰竭的临床效果。方法选取2010年5月至2012年5月就就诊于我院的56例充血性心力衰竭患者作为研究对象,随机分为观察组29例(倍他乐克与常规抗心力衰竭药物联合应用方案治疗),对照组27例(常规抗心力衰竭药物治疗),回顾性分析两组患者的临床效果。结果观察组患者心功能改善总有效率为93.1%;对照组患者心功能改善总有效率为77.7%,经统计分析,P<0.05,差异具有统计学意义。结论倍他乐克与常规抗心力衰竭药物联合应用方案是充血性心力衰竭的有效方法,建议临床深入研究。
Objective To investigate the clinical efficacy of combination of Betaloc with conventional anti-heart failure drugs in the treatment of congestive heart failure. Methods From May 2010 to May 2012, 56 patients with congestive heart failure treated in our hospital were selected and randomly divided into observation group (n = 29) (combination of metoprolol and conventional anti-heart failure drugs ), Control group of 27 cases (conventional anti-heart failure drug treatment), the clinical effects of two groups of patients were retrospectively analyzed. Results The total effective rate of heart function improvement was 93.1% in observation group and 77.7% in control group, P <0.05, the difference was statistically significant. Conclusion The combination of Betaloc with conventional anti-heart failure drugs is an effective method for congestive heart failure, and it is recommended to further study in clinic.